Nasdaq(NDAQ)
Search documents
Blue Hat Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
GlobeNewswire News Room· 2024-09-11 21:00
XIAMEN, China, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Blue Hat Interactive Entertainment Technology (“Blue Hat” or the “Company”) (NASDAQ: BHAT), today announced that on September 6, 2024, it has received a notification letter from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is not in compliance with the minimum bid price requirement from July 25, 2024 through September 5, 2024, as set forth in Nasdaq Listing Rules 5550(a)(2), which require that the closing bid price for the Company’s o ...
SigmaTron International, Inc. Regains Compliance with Nasdaq Listing Rule 5250(c)(1)
GlobeNewswire News Room· 2024-09-11 20:30
ELK GROVE VILLAGE, Ill., Sept. 11, 2024 (GLOBE NEWSWIRE) -- SigmaTron International, Inc. (NASDAQ: SGMA), an electronic manufacturing services company (the “Company”), announced today that on September 10, 2024, it received notice from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) indicating the Company has regained compliance with Nasdaq Listing Rule 5250(c)(1) by filing with the Securities and Exchange Commission (“SEC”) its Form 10-K for the annual period ended April 30, ...
Meiwu Technology Company Limited Received Nasdaq Notification Letter Regarding Bid Price Deficiency
GlobeNewswire News Room· 2024-09-11 20:15
Shenzhen, China, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Meiwu Technology Company Limited (“WNW” or the “Company”), (NASDAQ: WNW) announced today that on September 10, 2024, the Company received a notification letter from the Nasdaq Listing Qualifications Staff of The NASDAQ Stock Market LLC (“Nasdaq”) notifying the Company that the minimum bid price per share for its ordinary shares has been below $1.00 for a period of 30 consecutive business days and the Company therefore no longer meets the minimum bid price ...
Nasdaq Announces End of Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date August 30, 2024
GlobeNewswire News Room· 2024-09-11 20:05
NEW YORK, Sept. 11, 2024 (GLOBE NEWSWIRE) -- At the end of the settlement date of August 30, 2024, short interest in 3,037 Nasdaq Global MarketSM securities totaled 12,296,040,928 shares compared with 12,277,781,936 shares in 3,037 Global Market issues reported for the prior settlement date of August 15, 2024. The end of August short interest represent 3.38 days average daily Nasdaq Global Market share volume for the reporting period, compared with 2.62 days for the prior reporting period. Short interest in ...
bleuacacia receives notice of deficiency from Nasdaq
GlobeNewswire News Room· 2024-09-11 20:00
NEW YORK, Sept. 11, 2024 (GLOBE NEWSWIRE) -- bleuacacia ltd (NASDAQ: BLEU) announced today that on September 6, 2024, it received a notice (the “Notice”) from the Listing Qualifications department of The Nasdaq Stock Market LLC (“Nasdaq”) that the Company no longer complies with Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”), which requires companies with securities listed on Nasdaq to timely file all required periodic reports with the U.S. Securities and Exchange Commission (the “SEC”). As previously ...
Allarity Therapeutics Takes Decisive Step Toward Regaining Nasdaq Compliance with Nasdaq Listing Rule 5550(a)(2)
GlobeNewswire News Room· 2024-09-11 12:00
Boston (September 11, 2024) — Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a clinical-stage pharmaceutical company dedicated to developing personalized cancer treatments, today announced that the Company is taking a decisive step toward regaining compliance with Nasdaq’s listing requirements, as outlined by the Nasdaq Hearings Panel during a meeting on August 15, 2024. At the meeting, the Nasdaq Hearings Panel approved Allarity’s plan to maintain its listing, contingent upon the ...
History Says the Nasdaq Will Soar: 2 Growth Stocks With 26% and 38% Upside to Buy Now, According to Wall Street
The Motley Fool· 2024-09-11 09:00
Wall Street analysts forecast substantial upside for Amazon and Zscaler.The Nasdaq Composite (^IXIC 0.84%) closed in correction territory on Aug. 2, meaning it had fallen at least 10% from its bull market high. Worrisome labor market data factored heavily into the drawdown. The U.S. added fewer jobs than analysts anticipated in July, and unemployment reached its highest level since 2021.However, investors have good reason to be optimistic. The index tends to bounce back quickly. During the last 15 years, th ...
Aeries Technology Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q
GlobeNewswire News Room· 2024-09-10 21:00
NEW YORK, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Aeries Technology, Inc. (“Aeries Technology” or “the Company”) (Nasdaq: AERT), a global professional services and technology consulting partner, today announced that it received an expected deficiency notification letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC (“Nasdaq”) on September 5, 2024 (the “Notice”). The Notice indicated that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”) as a result ...
Crinetics Pharmaceuticals Announces September 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire News Room· 2024-09-10 20:40
SAN DIEGO, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on September 10, 2024, the Compensation Committee of Crinetics’ Board of Directors granted non-qualified stock option awards to purchase an aggregate of 120,200 shares of its common stock to fifteen new non-executive employees under the Crinetics Pharmaceuticals, Inc. 2021 Employment Inducement Incentive Award Plan (the “2021 Inducement Plan”). The stock options were granted as inducements mater ...
Telesis Bio Plans to Delist its Securities from The Nasdaq Stock Market
GlobeNewswire News Room· 2024-09-10 20:30
SAN DIEGO, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO) (“Telesis” or the “Company”), a leading provider of RNA and DNA solutions enabling researchers to accelerate therapeutic discovery through advanced, flexible, and rapid automated synthesis technology in their own lab, announced today that it has notified the Nasdaq Stock Market LLC (“Nasdaq”) of its decision to delist the Company’s shares of common stock, par value $0.001 per share (the “Common Stock”) and deregister the Common St ...